Biotech · Private company
Cell>Point LLC
Track this companyFree. Adds Cell>Point LLC to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- (99m Tc) ECDG (Ethylenedicysteine-Deoxyglucose)Phase 3 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- 18 F FDG followed by PET/CT imagingPhase 3 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- 99mTc-SestamibiPhase 2 · Coronary Artery DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD)PHASE2 · NOT_YET_RECRUITING · started May 10, 2025ClinicalTrials.gov NCT01899833 · fetched Nov 12, 2026
- A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung CancerPHASE3 · NOT_YET_RECRUITING · started May 1, 2025ClinicalTrials.gov NCT01394679 · fetched Nov 12, 2026